7.10 ALEMTUZUMAB solution for infusion, 10 mg mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). Purpose of Application - Alemtuzumab - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2015-03-16 01:05:14 Pharmacology Medicine Natalizumab Alemtuzumab Fingolimod Clinical trial Immunosuppressants Immunology Multiple sclerosis		7.10 ALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). Purpose of Application Add to Reading List Source URL: www.pbs.gov.au Download Document from Source Website File Size: 54,02 KB Share Document on Facebook

	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use LEMTRADA safely and effectively. See full prescribing information for LEMTRADA. LEMTRADA® (alemtuzumab) injection, DocID: 1tfam - View Document
	Allogeneic hematopoietic SCT for patients with autoimmune diseases DocID: 1pQwt - View Document
	UCT T-CELL DEPLETION: ALEMTUZUMAB IN THE BAG Nicolas Novitzky PhD, FCP(SA) DocID: 1k3Lh - View Document
	alemtuzumab (Lemtrada) Ordnat Införande i Samverkan DatumVersion 2.0 Ett samarbetsprojekt mellan Sveriges landsting & Regioner Alemtuzumab (Lemtrada) vid skovvis förlöpande MS DocID: 1bN6B - View Document
	7.10 ALEMTUZUMAB solution for infusion, 10 mg/ mL; Lemtrada®; Genzyme (Sanofi-Aventis Australia Pty Ltd). Purpose of Application DocID: 12AuW - View Document